Scott J. Dylla, Angel Investor

Scott J. Dylla is an Independent Biotech Angel Investor, Advisor, and Entrepreneur. He has significant experience working at the frontier where stem cell biology, oncology, and regenerative medicine intersect. Most recently, he has taken advantage of his experience and expertise to pioneer the development of new assay platforms to discover cancer stem cells and identify prospective therapeutic targets associated with these cells. His specialties include Stem Cell Biology, Molecular & Cellular Biology, Pathobiology, Target Identification & Validation, and Oncology. He's a Board Member at Aspera Biomedicines and Kineta (TuHURA Biosciences). He is a former Chairman of Chimera Bioengineering and a former Board Member at 3DBio Therapeutics.